CD27 Antikörper (AA 20-191) (HRP)
-
- Target Alle CD27 Antikörper anzeigen
- CD27 (CD27 Molecule (CD27))
-
Bindungsspezifität
- AA 20-191
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CD27 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human CD27 antigen protein (20-191AA)
- Isotyp
- IgG
- Top Product
- Discover our top product CD27 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CD27 (CD27 Molecule (CD27))
- Andere Bezeichnung
- CD27 (CD27 Produkte)
- Synonyme
- TNFRSF7 antikoerper, S152 antikoerper, Tnfrsf7 antikoerper, Tp55 antikoerper, S152. LPFS2 antikoerper, T14 antikoerper, CD27 molecule antikoerper, CD27 antigen antikoerper, CD27 antikoerper, Cd27 antikoerper
- Hintergrund
-
Background: Receptor for CD70/CD27L. May play a role in survival of activated T-cells. May play a role in apoptosis through association with SIVA1.
Aliases: CD 27 antibody, CD27 antibody, CD27 antigen antibody, CD27 Molecule antibody, CD27_HUMAN antibody, CD27L receptor antibody, LPFS2 antibody, MGC20393 antibody, OTTHUMP00000238557 antibody, S152 antibody, T cell activation antigen CD27 antibody, T cell antivation antigen S152 antibody, T-cell activation antigen CD27 antibody, T14 antibody, TNFRSF 7 antibody, TNFRSF7 antibody, TNFSF7 antibody, Tp 55 antibody, Tp55 antibody, Tumor necrosis factor receptor superfamily member 7 antibody
- UniProt
- P26842
- Pathways
- Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
-